FDA Commissioner Resigns Amid Turbulence in Regulatory Agency The tumultuous tenure of the Food and Drug Administration (FDA) commissioner has come to an end, sparking a mix of relief and concern among stakeholders.
Recent months have seen controversy over policy decisions, allegations of politicization, and criticism of handling high profile cases involving pharmaceutical companies.
Understanding the FDA Commissioner's Resignation: Context and Implications The events leading up to the resignation date back to early 2022, when the commissioner faced intense scrutiny over their handling of several high profile cases.